Clinical Trials in Spain

• Interventional Platform Study Investigating the Impact of Digital Health Solutions on Health Outcomes and Health-Care Resource Utilization i… Ended
  2023-504342-55-00 Phase II/III Cohort A: • Metastatic non-small cell lung carcinoma (mNSCL… F. Hoffmann-La Roche AG
• A study to learn how well the drug EDP-938 works and how safe it is for non-hospitalized Adults with Acute Respiratory Syncytial Virus Infec… Ended
  2024-513861-38-00 Phase II Respiratory syncytial virus (RSV) Enanta Pharmaceuticals Inc.
• Multicenter, Open-label, Single arm, Phase II Clinical Trial to Improve Sacituzumab Govitecan Tolerance in Patients with Metastatic Triple-N… Ended
  2024-514060-10-00 Phase II Advanced triple-negative breast cancer (TNBC), Advanced HR[+… Medica Scientia Innovation Research S.L.
• STRIDES - A Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia Ended
  2022-501004-10-00 Phase II/III Spinocerebellar Ataxia type-3 (SCA3) Seelos Therapeutics Inc.
• A 12-month, randomized, single-blind, placebo-controlled exposure-response study of TCD601 (siplizumab) in new onset type 1 diabetes patient… Ended
  2023-506837-31-00 Phase II New onset type I diabetes Itb-Med AB
• Quercus ilex and Quercus robur allergen extracts. Determination of in the vivo histamine equivalent prick test units (HEP). Ended
  2024-515189-14-00 Phase II Allergy to Quercus ilex and Quercus robur Inmunotek S.L.
• A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Ended
  2024-514761-19-00 Phase III Idiopathic Pulmonary Fibrosis United Therapeutics Corp.
• EFFICACY AND SAFETY TRIAL OF EPCORITAMAB WITH OR WITHOUT LENALIDOMIDE AS FIRST LINE THERAPY FOR SUBJECTS WITH DIFFUSE LARGE B-CELL LYMPHOMA. Ended
  2023-504832-16-00 Phase II DIFFUSE LARGE B CELL LYMPHOMA Genmab A/S
• A Study of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with R/R PTCL Ended
  2022-500391-62-00 Phase I/II Subjects with relapsed/refractory peripheral T-cell lymphoma… Taiho Oncology Inc.
• A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended
  2023-503793-20-00 Phase III Prevention of ischemic stroke in patients post acute non-car… Bayer AG
• A multi-center study to evaluate the safety, tolerability and efficacy of TIN816 in patients at risk for acute kidney injury following a car… Ended
  2024-511621-64-00 Phase II Acute kidney injury Novartis Pharma AG
• Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended
  2023-504238-23-00 Phase III Hepatitis B, Chronic Glaxosmithkline Research & Development Limited
• A trial to compare efficacy and safety of follitropin delta versus placebo (inactive treatment) in the treatment of men with idiopathic infe… Ended
  2023-508430-34-00 Phase II Idiopathic male infertility (including oligoasthenozoospermi… Ferring Pharmaceuticals A/S
• Efficacy of [18F]florbetaben PET for diagnosis of cardiac AL amyloidosis Ended
  2022-500186-27-00 Phase III ATTR Amyloidosis Lantheus Germany GmbH
• A Phase 1b, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activ… Ended
  2022-500116-18-00 Phase I (Other) Advanced Solid Tumors ADC Therapeutics S.A.
• Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 1) Ended
  2023-504239-41-00 Phase III Hepatitis B, Chronic Glaxosmithkline Research & Development Limited
• Phase 2 Study of MORAb-202 in Previously Treated Metastatic NSCLC AC Ended
  2023-504112-15-00 Phase II Metastatic Non-Small Cell Lung Cancer Bristol Myers Squibb International Corporation
• An Open Label Study to Evaluate A3907 in Adults with Primary Sclerosing Cholangitis (PSC) Ended
  2022-500790-14-00 Phase II Primary Sclerosing Cholangitis (PSC) Albireo AB
• Relatlimab + Nivolumab in Pediatric and Young Adult Lymphomas (RELATIVITY-069) Ended
  2023-503715-14-00 Phase I/II Recurrent or Refractory Classical Hodgkin Lymphoma and Non-H… Bristol Myers Squibb International Corporation
• An extension of the orchestra (PD0053) study to learn how safe minzasolmin is and if it works long-term in participants with Parkinson’s dis… Ended
  2022-500424-30-00 Phase II Parkinson’s disease UCB Biopharma
• Study to assess safety and identify dose of ribociclib in combination of temozolomide and topotecan (TOTEM) in patients (12 months – 21 year… Ended
  2024-512095-35-00 Phase I/II Relapsed or refractory neuroblastoma and other solid tumors … Novartis Pharma AG
• A Phase 1, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activi… Ended
  2022-500115-39-00 Phase I Advanced Solid Tumors ADC Therapeutics S.A.
• Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus I… Ended
  2024-511755-18-00 Phase III Invasive Candidiasis/ Candidemia Scynexis Inc.
• A first-in-human clinical trial in adult patients with metastatic or recurrent melanoma of a personalised therapy targeting specific mutatio… Ended
  2024-513062-19-00 Phase I (FiH) Metastatic or recurrent melanoma Achilles Therapeutics UK Limited

Showing 4,153–4,176 of 4,852 trials